ILDSTAD SUZANNE (Chief Scientific Officer) sold 0.3% of their position (10.44K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $21.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2023ACC: 0001209191-23-020049
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-10.44K
Net shares
Net seller
$21.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.44K
Price / share
$2.06
Trade value
$21.54K
% of position
0.3%
3/17/2023
3.06M→3.05M
Total
Net shares
−10.44K
Net value
-$21.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2023 | S · Sale | −10.44K | $2.06 | $21.54K | 0.3% | 3.06M | 3.05M |
| Total | −10.44K | -$21.54K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned654.21K
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported